Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$191.17 - $325.63 $244,124 - $415,829
1,277 Added 3.38%
39,038 $12.7 Million
Q4 2023

Feb 12, 2024

BUY
$160.99 - $215.69 $49,906 - $66,863
310 Added 0.83%
37,761 $7.2 Million
Q3 2023

Nov 09, 2023

BUY
$194.33 - $283.97 $217,260 - $317,478
1,118 Added 3.08%
37,451 $7.46 Million
Q2 2023

Aug 11, 2023

SELL
$223.05 - $302.68 $202,975 - $275,438
-910 Reduced 2.44%
36,333 $10.4 Million
Q1 2023

May 09, 2023

BUY
$175.41 - $217.92 $1.05 Million - $1.31 Million
6,005 Added 19.22%
37,243 $8.08 Million
Q4 2022

Feb 09, 2023

BUY
$204.38 - $296.82 $500,731 - $727,209
2,450 Added 8.51%
31,238 $6.42 Million
Q3 2022

Nov 07, 2022

BUY
$195.21 - $310.53 $1.42 Million - $2.25 Million
7,255 Added 33.69%
28,788 $8.01 Million
Q2 2022

Aug 11, 2022

BUY
$115.91 - $214.48 $363,957 - $673,467
3,140 Added 17.07%
21,533 $4.12 Million
Q1 2022

May 12, 2022

BUY
$127.96 - $207.36 $50,544 - $81,907
395 Added 2.19%
18,393 $3.81 Million
Q4 2021

Feb 08, 2022

BUY
$165.13 - $241.83 $249,016 - $364,679
1,508 Added 9.14%
17,998 $3.21 Million
Q3 2021

Nov 09, 2021

BUY
$163.99 - $235.57 $1.72 Million - $2.47 Million
10,465 Added 173.69%
16,490 $3.4 Million
Q1 2021

May 11, 2021

BUY
$92.73 - $142.05 $27,819 - $42,615
300 Added 5.24%
6,025 $785,000
Q4 2020

Feb 04, 2021

BUY
$67.44 - $103.72 $144,996 - $222,998
2,150 Added 60.14%
5,725 $594,000
Q3 2020

Nov 05, 2020

BUY
$42.79 - $75.8 $152,974 - $270,985
3,575 New
3,575 $271,000
Q3 2019

Nov 05, 2019

SELL
$29.71 - $55.23 $274,817 - $510,877
-9,250 Closed
0 $0
Q2 2019

Aug 06, 2019

BUY
$29.73 - $66.02 $275,002 - $610,685
9,250 New
9,250 $528,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Biondo Investment Advisors, LLC Portfolio

Follow Biondo Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biondo Investment Advisors, LLC with notifications on news.